
The advantages of synthetic advisory boards in stress-testing hypotheses and iterating across a greater scope of scenarios than live boards allow.

Aisling O'Loughlin, Ph.D., is a Principal at IQVIA working at the intersection of AI, innovation and strategy consulting. She leads AI and advanced analytics engagements, applying algorithms along the patient journey and across the asset lifecycle to draw meaningful value from data, and pairs big data, models and bespoke technology with human expertise to support better-informed, faster decisions. She holds a doctorate in gene therapy and neuroscience and an MSc in neuroscience from the University of Oxford, and a BSc in neuroscience and pharmacology from University College Dublin.

The advantages of synthetic advisory boards in stress-testing hypotheses and iterating across a greater scope of scenarios than live boards allow.